Correction: Tep et al., Oral Administration of a Small Molecule Targeted to Block proNGF Binding to p75 Promotes Myelin Sparing and Functional Recovery after Spinal Cord Injury

In the article “Oral Administration of a Small Molecule Targeted to Block proNGF Binding to p75 Promotes Myelin Sparing and Functional Recovery after Spinal Cord Injury” by Chhavy Tep, Tae Hee Lim, Pyung On Ko, Sami Getahun, Jae Cheon Ryu, Virginia M. Goettl, Stephen M. Massa, Michele Basso, Frank M. Longo, and Sung Ok Yoon, which appeared on pages 397–410 of the January 9, 2013 issue, one of the authors failed to disclose a financial conflict of interest. Dr. Stephen Massa was listed as an inventor on a patent (US7723328 B2) covering the small molecules described in the paper. The reviewers and the editors were unaware of this interest at the time the paper was reviewed.